One-third of seniors with cognitive disorders prescribed potentially harmful CNS drugs

Adults aged 65 and older who have cognitive disorders such as dementia are experiencing heightened adverse effects from medications used to treat central nervous system (CNS) conditions, according to recent health data. The drugs in question, which address anxiety, sleep disturbances, and psychosis, appear to interact more negatively with the brains of seniors suffering from cognitive impairment, leading to a cascade of health complications.

The increased susceptibility has translated into a measurable rise in emergency department visits and longer, more frequent hospital stays for this population. Researchers also note a correlation with deteriorating mental health outcomes and an elevated risk of premature mortality among affected individuals. Health officials emphasize the need for careful prescribing practices and closer monitoring to mitigate these risks and improve overall care for older adults with dementia and related disorders.